Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia

Nutrients

Volumn 7, Issue 5, 2015, Pages 3767-3782

  Huang, Wen Ching ^a   Chen, Yi Ming ^a   Kan, Nai Wen ^a,b   Ho, Chun Sheng ^a,c   Wei, Li ^b   Chan, Ching Hung ^d   Huang, Hui Yu ^d   Huang, Chi Chang ^a  

^a NATIONAL TAIWAN SPORT UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c LOTUNG POH AI HOSPITAL   (Taiwan)

^d SHIH CHIEN UNIVERSITY   (Taiwan)

Author keywords

Cholesterol; High cholesterol diet; Hypolipidemic; Lipid lowering; Triglyceride

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BIOCHEMISTRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FECES ANALYSIS; HAMSTER; HISTOLOGY; HISTOPATHOLOGY; HYPOLIPEMIA; LACTOBACILLUS REUTERI; LIPID ANALYSIS; MALE; NONHUMAN; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; FATTY LIVER; FECES; HYPERLIPIDEMIAS; LIPID DIET; LIVER; MESOCRICETUS; METABOLISM; PATHOLOGY;

CRICETINAE; LACTOBACILLUS REUTERI; MESOCRICETUS AURATUS;

ANIMALS; CHOLESTEROL; CRICETINAE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; FECES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LACTOBACILLUS REUTERI; LIVER; MALE; MESOCRICETUS; PROBIOTICS; TRIGLYCERIDES;

EID: 84929340008     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7053767     Document Type: Article

References (39)

1. Tsai, T. Y.; Chu, L. H.; Lee, C. L.; Pan, T. M. Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk soymilk supplemented with Momordica charantia. J. Agric. Food Chem. 2009, 57, 2065-2071.
2. Jones, M. L.; Martoni, C. J.; Parent, M.; Prakash, S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br. J. Nutr. 2012, 107, 1505-1513.
3. Ljungh, A.; Wadström, T. Lactobacillus Molecular Biology: From Genomics to Probiotics. Caister Academic Press: Norfolk, England, 2009.
4. Chen, Y. M.; Shih, T. W.; Chiu, C. P.; Pan, T. M.; Tsai, T. Y. Effects of lactic acid bacteria-fermented soy milk on melanogenesis in B16F0 melanocytes. J. Funct. Foods 2013, 5, 395-405.
5. Noohi, N.; Ebrahimipour, G.; Rohani, M.; Talebi, M.; Pourshafie, M. R. Phenotypic characteristics and probiotic potentials of Lactobacillus spp. isolated from poultry. Jundishapur J. Microbiol. 2014, 7, e17824, doi: 10. 5812/jjm. 17824.
6. Talarico, T. L.; Casas, I. A.; Chung, T. C.; Dobrogosz, W. J. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1988, 32, 1854-1858.
7. Ojetti, V.; Ianiro, G.; Tortora, A.; D'Angelo, G.; di Rienzo, T. A.; Bibbò, S.; Gasbarrini, A. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: A randomized, double-blind, placebo-controlled trial. J. Gastrointestin. Liver Dis. 2014, 23, 387-391.
8. Holz, C.; Busjahn, A.; Mehling, H.; Arya, S.; Boettner, M.; Habibi, H.; Lang, C. Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. Probiotics Antimicrob. Proteins 2014, doi: 10. 1007/s12602-014-9181-3.
9. Sima, A.; Bulla, A.; Simionescu, N. Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J. Submicrosc. Cytol. Pathol. 1990, 22, 1-16.
10. Sullivan, M. P.; Cerda, J. J.; Robbins, F. L.; Burgin, C. W. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab. Anim. Sci. 1993, 43, 575-578.
11. Stancu, C. S.; Sanda, G. M.; Deleanu, M.; Sima, A. V. Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters. Mol. Nutr. Food. Res. 2014, 58, 559-568.
12. Qiao, Y.; Sun, J.; Xia, S.; Li, L.; Li, Y.; Wang, P.; Shi, Y.; Le, G. Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model. J. Funct. Foods 2015, 14, 424-434.
13. Singh, T. P.; Malik, R. K.; Katkamwar, S. G.; Kaur, G. Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet. Int. J. Food Sci. Nutr. 2015, 66, 71-75.
14. Chen, W. C.; Huang, W. C.; Chiu, C. C.; Chang, Y. K.; Huang, C. C. Whey protein improves exercise performance and biochemical profiles in trained mice. Med. Sci. Sports Exerc. 2014, 46, 1517-1524.
15. Yang, L.; Leung, K. Y.; Cao, Y.; Huang, Y.; Ratnayake, W. M.; Chen, Z. Y. Alpha-linolenic acid but not conjugated linolenic acid is hypocholesterolaemic in hamsters. Br. J. Nutr. 2005, 93, 433-438.
16. Liu, X. M.; Wu, F. H. Comparison of animal models of hyperlipidemia. Zhong Xi Yi Jie He Xue Bao 2004, 2, 132-134.
17. Zhang, Z.; Wang, H.; Jiao, R.; Peng, C.; Wong, Y. M.; Yeung, V. S.; Huang, Y.; Chen, Z. Y. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 2009, 53, 921-930.
18. Gao, Y.; Li, K.; Tang, S.; Xiao, Y. Study on animal models for hyperlipidemia. Wei Sheng Yan Jiu 2002, 31, 97-99.
19. Lee, C. L.; Tsai, T. Y.; Wang, J. J.; Pan, T. M. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl. Microbiol. Biotechnol. 2006, 70, 533-540.
20. Lee, C. L.; Hung, H. K.; Wang, J. J.; Pan, T. M. Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. J. Agric. Food Chem. 2007, 55, 7162-7169.
21. Chen, W.; Fan, S.; Xie, X.; Xue, N.; Jin, X.; Wang, L. Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster. PLoS ONE. 2014, 9, e96056, doi: 10. 1371/journal. pone. 0096056.
22. Yonejima, Y.; Ushida, K.; Mori, Y. Effect of lactic acid bacteria on lipid metabolism and fat synthesis in mice fed a high-fat diet. Biosci. Microbiota Food Health 2013, 32, 51-58.
23. Pereira, D. I.; Gibson, G. R. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit. Rev. Biochem. Mol. Biol. 2002, 37, 259-281.
24. Taranto, M. P.; Medici, M.; Perdigon, G.; Ruiz Holgado, A. P.; Valdez, G. F. Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J. Dairy Sci. 2000, 83, 401-403.
25. Barona, J.; Fernandez, M. L. Dietary cholesterol affects plasma lipid levels, the intravascular processing of lipoproteins and reverse cholesterol transport without increasing the risk for heart disease. Nutrients 2012, 4, 1015-1025.
26. Taranto, M. P.; Fernandez Murga, M. L.; Lorca, G.; de Valdez, G. F. Bile salts and cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri. J. Appl. Microbiol. 2003, 95, 86-91.
27. Begley, M.; Hill, C.; Gahan, C. G. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 2006, 72, 1729-1738.
28. Tsai, C. C.; Lin, P. P.; Hsieh, Y. M.; Zhang, Z. Y.; Wu, H. C.; Huang, C. C. Cholesterol-lowering potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo. Sci. World J. 2014, doi: 10. 1155/2014/690752.
29. Friedman, M.; Fitch, T. E.; Levin, C. E.; Yokoyama, W. H. Feeding tomatoes to hamsters reduces their plasma low-density lipoprotein cholesterol and triglycerides. J. Food Sci. 2000, 65, 897-900.
30. Mencarelli, A.; Cipriani, S.; Renga, B.; Bruno, A.; D'Amore, C.; Distrutti, E.; Fiorucci, S. VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One. 2012, 7, e45425, doi: 10. 1371/journal. pone. 0045425.
31. Kobayashi, M.; Egusa, S.; Fukuda, M. Isoflavone and protein constituents of lactic acid-fermented soy milk combine to prevent dyslipidemia in rats fed a high cholesterol diet. Nutrients 2014, 6, 5704-5723.
32. Jo, S. Y.; Choi, E. A.; Lee, J. J.; Chang, H. C. Characterization of starter kimchi fermented with Leuconostoc kimchii GJ2 and its cholesterol-lowering effects in rats fed a high-fat and high-cholesterol diet. J. Sci. Food Agric. 2014, doi: 10. 1002/jsfa. 7018.
33. Chawda, H. M.; Mandavia, D. R.; Parmar, P. H.; Baxi, S. N.; Tripathi, C. R. Hypolipidemic activity of a hydroalcoholic extract of Cyperus scariosus Linn. root in guinea pigs fed with a high cholesterol diet. Chin. J. Nat. Med. 2014, 12, 819-826.
34. Gilat, T.; Leikin-Frenkel, A.; Goldiner, I.; Juhel, C.; Lafont, H.; Gobbi, D.; Konikoff, F. M. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC). Hepatology 2003, 38, 436-442.
35. Hathout, A. S.; Mohamed, S. R.; El-Nekeety, A. A.; Hassan, N. S.; Aly, S. E.; Abdel-Wahhab, M. A. Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet. Toxicon 2011, 58, 179-186.
36. Forsberg, A.; Abrahamsson, T. R.; Björkstén, B.; Jenmalm, M. C. Pre-and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin. Exp. Allergy 2013, 43, 434-442.
37. Martoni, C.; Bhathena, J.; Jones, M. L. Investigation of microencapsulated BSH active Lactobacillus in the simulated human GI tract. J. Biomed. Biotechnol. 2007, 2007, 1-9.
38. Ooi, L. G.; Ahmad, R.; Yuen, K. H. Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J. Dairy. Sci. 2010, 93, 5048-5058.
39. Jones, M. L.; Martoni, C. J.; Prakash, S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. Eur. J. Clin. Nutr. 2012, 66, 1234-1241.